In a rush to decide: Deep brain stimulation and dopamine agonist therapy in Parkinson's disease

Journal of Parkinson's Disease

Volumn 4, Issue 4, 2014, Pages 579-583

  Djamshidian, Atbin ^a   O'Sullivan, Sean S ^b   Tomassini, Alessandro ^c   Foltynie, Thomas ^c   Limousin, Patricia ^c   Aviles Olmos, Iciar ^c   Warner, Thomas T ^a   Lees, Andrew J ^a   Averbeck, Bruno B ^d  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b Department of Medicine National University of Ireland Cork   (Ireland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Deep brain stimulation; dopamine agonists; Parkinson's disease; perceptual decision making

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DECISION MAKING; DOPAMINE BRAIN LEVEL; ERROR; FEMALE; HUMAN; MALE; MONOTHERAPY; PARKINSON DISEASE; PERCEPTIVE THRESHOLD; POLYPHARMACY; RESPONSE TIME; RISK FACTOR; SUBTHALAMIC NUCLEUS; TASK PERFORMANCE; AGED; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; DRUG EFFECTS; MENTAL HEALTH; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; PROCEDURES; REACTION TIME; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; DEEP BRAIN STIMULATION; DOPAMINE AGONISTS; FEMALE; HUMANS; LEVODOPA; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PARKINSON DISEASE; REACTION TIME; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 84914672646     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-140388     Document Type: Article

References (20)

1. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, & Benabid AL (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet, 345, 91-95.
2. Frank MJ, Samanta J, Moustafa AA, & Sherman SJ (2007) Hold your horses: Impulsivity, deep brain stimulation, and medication in parkinsonism. Science, 318, 1309-1312.
3. Djamshidian A, O'Sullivan S, Foltynie T, Aviles-Olmos I, Limousin P, Noyce A, Zrinzo L, Lees A, & Averbeck BB (2013) Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease. Journal of Parkinson's disease, 3, 139-144.
4. Moum SJ, Price CC, Limotai N, Oyama G, Ward H, Jacobson C, Foote KD,&Okun MS (2012) Effects ofSTNand GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome. PLoS One, 7, e29768.
5. Lhommee E, Klinger H, Thobois S, Schmitt E, Ardouin C, Bichon A, Kistner A, Fraix V, Xie J, Aya Kombo M, Chabardes S, Seigneuret E, Benabid AL, Mertens P, Polo G, Carnicella S, Quesada JL, Bosson JL, Broussolle E, Pollak P, &Krack P (2012) Subthalamic stimulation in Parkinson's disease: Restoring the balance of motivated behaviours. Brain, 135, 1463-1477.
6. Lim SY, O'Sullivan SS, Kotschet K, Gallagher DA, Lacey C, Lawrence AD, Lees AJ, O'Sullivan DJ, Peppard RF, Rodrigues JP, Schrag A, Silberstein P, Tisch S, & Evans AH (2009) Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci, 16, 1148-1152.
7. Cavanagh JF, Wiecki TV, Cohen MX, Figueroa CM, Samanta J, Sherman SJ, & Frank MJ (2011) Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci, 14, 1462-1467.
8. Ye Z, Hammer A, Camara E,&Munte TF (2011) Pramipexole modulates the neural network of reward anticipation. Hum Brain Mapp, 32, 800-811.
9. Green N, Bogacz R, Huebl J, Beyer AK, Kuhn AA, & Heekeren HR (2013) Reduction of influence of task difficulty on perceptual decision making by STN deep brain stimulation. Curr Biol, 23, 1681-1684.
10. Folstein MF, Folstein SE,&McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12, 189-198.
11. Gibb WR, & Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry, 51, 745-752.
12. Seo M, Lee E, & Averbeck BB (2012) Action selection and action value in frontal-striatal circuits. Neuron, 74, 947-960.
13. Coulthard EJ, Bogacz R, Javed S, Mooney LK, Murphy G, Keeley S, & Whone AL (2012) Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making. Brain, 135, 3721-3734.
14. Voon V, Reynolds B, Brezing C, Gallea C, Skaljic M, Ekanayake V, Fernandez H, Potenza MN, Dolan RJ, & Hallett M (2010) Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl), 207, 645-659.
15. Demetriades P, Rickards H, & Cavanna AE (2011) Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: Clinical aspects. Parkinsons Di, 20, 658415.
16. Wyvell CL, & Berridge KC (2000) Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: Enhancement of reward "wanting" without enhanced "liking" or response reinforcement. J Neurosci, 20, 8122-8130.
17. Nagy H, Levy-Gigi E, Somlai Z, Takats A, Bereczki D,&Keri S (2012) The effect of dopamine agonists on adaptive and aberrant salience in Parkinson's disease. Neuropsychopharmacology, 37, 950-958.
18. Wylie SA, Ridderinkhof KR, Elias WJ, Frysinger RC, Bashore TR, Downs KE, vanWouwe NC, & van den Wildenberg WP (2010) Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease. Brain, 133, 3611-3624.
19. Lim SY, Evans AH, & Miyasaki JM (2008) Impulse control and related disorders in Parkinson's disease: Review. Ann N Y Acad Sci, 1142, 85-107.
20. Averbeck BB, O'Sullivan SS,&Djamshidian A(2014) Impulsive and compulsive behaviors in Parkinson's disease. Annu Rev Clin Psychol, 10, 553-580.